The biotech and genetic diagnostics company, QIAGEN, is ready to talk about a takeover. Between 23 July and 8 October, their share price fell by around...
Genfit announced results from a study demonstrating that NIS4, a non-invasive blood diagnostic tool developed for the diagnosis of non-alcoholic steatohepatitis (NASH), performed better than other...